Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
NCT: NCT07548164 · RECRUITING
広告
NCT識別子NCT07548164
ステータスRECRUITING
開始日2026-04-16
完了2029-04-16
SponsorMemorial Sloan Kettering Cancer Center (OTHER)
First posted
Last updated
概要
In this study the investigators will find out whether the use of a new type of boost approach called irreversible electroporation (IRE) is as effective as the standard boost approach of radiation therapy for participants with intermediate-risk prostate cancer receiving standard stereotactic body radiotherapy (SBRT).
公式ソース
ClinicalTrials.govで見る →データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。